Phase 2 Cystic Fibrosis Trial, Recruiting (NCT02641769)

Phase 2 Cystic Fibrosis Trial, Recruiting NCT02641769 Sponsor: Stem Cells Arabia Condition: Cystic Fibrosis

Printed from Voxsanity (voxsanity.com.au) — NCT02641769 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Cystic Fibrosis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Men who have been diagnosed as infertile and have had it confirmed that they produce no sperm due to a production problem in the testicles (rather than a blockage)

Who may not be able to join:

Men whose lack of sperm is caused by a blockage in the reproductive tract (rather than a sperm production problem)
Men who have previously had surgery on their testicles
Men who have an active infectious disease affecting their reproductive organs
Men who have physical abnormalities in the structure of their reproductive tract
Men who have serious medical conditions such as cancer
Men who have certain genetic or chromosomal abnormalities, for example a missing piece of the Y chromosome or an extra chromosome (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 22 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Adeeb AlZoubi, PhD, Stem Cells of Arabia

Phone: 00962795337575

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT02641769

Sponsor: Stem Cells Arabia

Phase: Phase 2

Status: Recruiting

Condition: Cystic Fibrosis

Trial contact: 00962795337575

More information: https://clinicaltrials.gov/study/NCT02641769

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Men who have been diagnosed as infertile and have had it confirmed that they produce no sperm due to a production problem in the testicles (rather than a blockage)

Who may not be able to join:

Men whose lack of sperm is caused by a blockage in the reproductive tract (rather than a sperm production problem)
Men who have previously had surgery on their testicles
Men who have an active infectious disease affecting their reproductive organs
Men who have physical abnormalities in the structure of their reproductive tract
Men who have serious medical conditions such as cancer
Men who have certain genetic or chromosomal abnormalities, for example a missing piece of the Y chromosome or an extra chromosome (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 22 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Stem Cells Arabia

Registry

ClinicalTrials.gov

Start date

1 January 2014

Est. completion

1 June 2030

Where this trial is recruiting

🇯🇴 Jordan

Primary endpoints

Appearance of spermatozoa in different maturation stages including primary spermatocytes, spermatids, and mature spermatozoa. Samples to be tested are either seminal fluid or testicular tissue obtained via fine needle aspiration (FNA) or surgical means.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov